1-3 of 3
Ashish M. Kamat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

1,1-Bis(3′-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth

Teruo Inamoto, Sabitha Papineni, Sudhakar Chintharlapalli, Sung-Dae Cho, Stephen Safe, Ashish M. Kamat
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (12): 3825–3833.
https://doi.org/10.1158/1535-7163.MCT-08-0730
Published: 15 December 2008
View article titled, 1,1-Bis(3′-indolyl)-1-(<em>p</em>-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth
Open the PDF for 1,1-Bis(3′-indolyl)-1-(<em>p</em>-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth in another window
Includes: Supplementary data
Journal Articles

Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-κB and nuclear factor-κB–regulated gene products in IFN-α–sensitive and IFN-α–resistant human bladder cancer cells

Ashish M. Kamat, Gautam Sethi, Bharat B. Aggarwal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (3): 1022–1030.
https://doi.org/10.1158/1535-7163.MCT-06-0545
Published: 15 March 2007
View article titled, Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-κB and nuclear factor-κB–regulated gene products in IFN-α–sensitive and IFN-α–resistant human bladder cancer cells
Open the PDF for Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-κB and nuclear factor-κB–regulated gene products in IFN-α–sensitive and IFN-α–resistant human bladder cancer cells in another window
Journal Articles

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo

Ashish M. Kamat, Takashi Karashima, Darren W. Davis, Laura Lashinger, Menashe Bar-Eli, Randall Millikan, Yu Shen, Colin P. N. Dinney, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (3): 279–290.
https://doi.org/10.1158/1535-7163.279.3.3
Published: 16 March 2004
View article titled, The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors <em>in vivo</em>
Open the PDF for The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors <em>in vivo</em> in another window